Govt Job: For M.Pharm, M.Sc under SERB-CRG funded project

Established in 1955 by the visionary industrialist Mr. BM Birla, BIT Mesra was founded with a clear vision to offer its young minds a space, where their imagination could take wings and their ideas fruition.

For over 6 decades now, the institute has nurtured minds with a rich heritage of academic excellence, developing learning frameworks that have been well ahead of times.

Post : Junior Research Fellow (JRF)

Applications are invited for the post of Junior Research Fellow in following project funded under SERB-CRG (2022-2025)

Project title : Development of Novel Antileukemics Through the Structural and Functional Studies of Engineered and Chimeric Plant-Type Asparaginases File No.: CRG//2021/006543

Name of PI& Co-PI : Dr. K K Pradhan, Dr. V K Nigam & Dr. H R Singh

Eligibility : M.Tech./ M.S/ M.Pharm./ M.Sc. in Bioengineering / Biotechnology / Pharm. Biotechnology. NET / GATE / GPAT or other national level examination qualifiers will be preferred.

Desirable skills : Design of Protein expression & purification, Local engineering (circular permutation, linker modification, motifs exchange, randomization),QbD, chimera-genesis and Exposure in SDS-PAGE as well as XRD techniques.

Duration : Initially for a period of 01 year & may be extended for a additional 02 year upon satisfactory performance

Felloship Rs/-pm : 31,000/- + HRA as applicable (First 2 Years) 35,000/- + HRA as applicable (Third Year)

Date and time of Interview :26th April 2022 & at 9.15 AM

Venue : Department of Pharmaceutical Sciences& Technology, BIT-Mesra

• Interested candidates are required to bring all original Certificates and testimonials along with one set of duly attested photocopy on the interview date. No TA/DA will be provided for attending the Interview.

• Candidates may please forward their Bio-data in advance to Dr. Kishanta Kumar Pradhan (Principal Investigator of the Project) through e-mail (kkpradhan@bitmesra.ac.in)

• Candidates appearing for online/offline interview should covey in advance to the PI.

• Selected candidate are expected to enroll for Ph.D. program of the institute after fulfilling admission criteria and would be given preference.

Terms & Conditions :
1. No TA/DA will be paid for attending the interview.
2. The above position is purely contractual.
3. Canvassing in any form will disqualify the candidate.

Related Posts

Governments have moved for Price Transparency in Hospitals to help patients cope with bills

AiMeD welcomes, also offering help design a Uniform National Framework for Holistic Transparency New Delhi/ Bangalore: Central government and Karnataka government have initiated measures to bring about greater transparency in…

The Most Innovative Medical Devices of 2026: Breakthrough Technologies Target Heart Disease, Cancer, Neurological Disorders and Kidney Dysfunction

NEW DELHI: Medical technology innovation is entering a new phase, with advanced cardiac implants, incisionless brain surgery, blood-based cancer screening, smart insulin delivery and real-time kidney-function monitoring among the technologies…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Governments have moved for Price Transparency in Hospitals to help patients cope with bills

Governments have moved for Price Transparency in Hospitals to help patients cope with bills

The Most Innovative Medical Devices of 2026: Breakthrough Technologies Target Heart Disease, Cancer, Neurological Disorders and Kidney Dysfunction

The Most Innovative Medical Devices of 2026: Breakthrough Technologies Target Heart Disease, Cancer, Neurological Disorders and Kidney Dysfunction

Three arrested after liquor bottles found at pharma firm

Three arrested after liquor bottles found at pharma firm

NEXUS 2026 brings pharma experts together to explore next generation analytical technologies

NEXUS 2026 brings pharma experts together to explore next generation analytical technologies

National Formulary of India 2026 Lists Unapproved Drugs; DCGI Seeks Urgent Explanation from IPC Over Regulatory Discrepancy

National Formulary of India 2026 Lists Unapproved Drugs; DCGI Seeks Urgent Explanation from IPC Over Regulatory Discrepancy

Six leading mental health organisations unite to launch ‘Humanising Medicine India Initiative’ on World Mental Health Day

Six leading mental health organisations unite to launch ‘Humanising Medicine India Initiative’ on World Mental Health Day